Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest announcement is out from Numinus Wellness ( (TSE:NUMI) ).
Numinus Wellness Inc. has announced a delay in the filing of its audited annual financial statements, resulting in a management cease trade order (MCTO) issued by the British Columbia Securities Commission. This order restricts the trading activities of the company’s executives until the filings are complete but does not affect shareholders’ ability to trade. The company is working diligently to complete the filings by January 28, 2025, while continuing to update stakeholders bi-weekly, ensuring transparency and compliance with regulatory guidelines.
More about Numinus Wellness
Numinus Wellness Inc. is a leader in the mental health care industry, known for its innovative and evidence-based treatments. The company focuses on developing and delivering psychedelic-assisted therapies to aid in healing depression, anxiety, trauma, pain, and substance use. Numinus is at the forefront of integrating these therapies into mainstream clinical practice, aiming to transform mental health care from symptom management to healing.
YTD Price Performance: 12.50%
Average Trading Volume: 681,621
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$14.5M
See more data about NUMI stock on TipRanks’ Stock Analysis page.
